As part of a Surfing NASH 3rd Anniversary Special, Louise Campbell and Roger Green interview CEO and Co-Founder of Inventiva Pharma, Frédéric Cren, to explore the trajectory of NASH therapeutics and Inventiva’s lead product candidate, lanifibranor.
As part of a Surfing NASH 3rd Anniversary Special, Louise Campbell and Roger Green interview CEO and Founder of the Global Liver Institute, Donna Cryer, to discuss the last three years and the future of fighting fatty liver disease.
As part of the podcast’s 3rd Anniversary Special, Louise Campbell and Roger Green interview Amy Articolo of Novo Nordisk to discuss the last three years and the future of fighting fatty liver disease.
The Surfing NASH 3rd Anniversary Special offers a look back at the history of the podcast and the future of Fatty Liver with the Surfers and interviewees Amy Articolo, Donna Cryer and Frédéric Cren.
In this episode From the Vault, The SurfingNASH team (Jörn Schattenberg, Louise Campbell, Roger Green) join Global Liver Institute NASH Programs Director Jeff McIntyre for the wrap-up panel of #NASHDay 2022.
The Surfers brainstorm ways we can all Step Up to NASH as the global liver community approaches #NASHDay on June 8th.
The Surfers discuss ways which different communities can become involved in #NASHDay 2023.
The Surfers explore elements of 2022 that have produced ripples in the pond of liver disease. Donna Cryer speaks to seeding investments in the global community and how these partnerships have made a measurable impact for the field.
Donna Cryer shares this year’s #NASHDay theme, Step Up to NASH, while Pamela Danagher and Jörn Schattenberg offer their first takes on what makes June 8th so special.
Donna Cryer describes Global Liver Institute’s journey of growing #NASHDay over the last six years and strengthening its impact on fighting fatty liver with an engaged global community.
